The effects of adjuvant insulin therapy among pregnant women with IGT who failed to achieve the desired glycemia levels by diet and moderate physical activity

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue 10, 2012, Pages 2028-2034

  Gojnic, Miroslava ^a,b   Perovic, Milan ^c   Pervulov, Miroslava ^a,b   Ljubic, Aleksandar ^a,b  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c Clinical Hospital Centre   (Serbia)

Author keywords

Fetal liver length; HbA1c; OGTT; Perinatal outcome; Placental thickness; Postprandial glycemia; Ultrasonography

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; BIRTH WEIGHT; CESAREAN SECTION; DIET THERAPY; ECHOGRAPHY; EDEMA; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY TEST; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHEMOTHERAPY, ADJUVANT; DIABETES, GESTATIONAL; DIET THERAPY; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EXERCISE THERAPY; FEMALE; GLUCOSE METABOLISM DISORDERS; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN, ISOPHANE; INSULIN, REGULAR, HUMAN; INSULIN, REGULAR, PORK; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84866374261     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2012.672598     Document Type: Article

References (51)

1. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2004, 27: 88-90.
2. Hanna FW, Peters JR. Screening for gestational diabetes; past, present and future. Diabet Med 2002;19:351-358. (Pubitemid 34534208)
3. Tieu J, Middleton P, McPhee AJ, Crowther CA. Screening and subsequent management for gestational diabetes for improving maternal and infant health. Cochrane Database Syst Rev 2010;7:CD007222.
4. Perovic M, Garalejic E, Gojnic M, Arsic B, Pantic I, Bojovic DJ, Fazlagic A, Gardiner H. Sensitivity and specificity of ultrasonography as a screening tool for gestational diabetes mellitus. J Matern Fetal Neonatal Med 2011; DOI: 10.3109/14767058.2011.634458.
5. Murgia C, Berria R, Minerba L, Sulis S, Murenu M, Portoghese E, Garau N, et al. Risk assessment does not explain high prevalence of gestational diabetes mellitus in a large group of Sardinian women. Reprod Biol Endocrinol 2008;6:26.
6. Moses R, Griffiths R, Davis W. Gestational diabetes: do all women need to be tested? Aust N Z J Obstet Gynaecol 1995;35:387-389.
7. Di Cianni G, Volpe L, Lencioni C, Miccoli R, Cuccuru I, Ghio A, Chatzianagnostou K, et al. Prevalence and risk factors for gestational diabetes assessed by universal screening. Diabetes Res Clin Pract 2003;62:131-137. (Pubitemid 37315888)
8. Perkins JM, Dunn JP, Jagasia SM. Perspectives in gestational diabetes mellitus: a review of screening, diagnosis, and treatment. Clin Diabet 2007; 25: 57-62. (Pubitemid 46743325)
9. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of yperglycemia in pregnancy. Diabetes Care. 2010; 33:676-682.
10. Rowan JA, Gao W, Hague WM, McIntyre HD. Glycemia and its relationship to outcomes in the metformin in gestational diabetes trial. Diabetes Care 2010;33:9-16.
11. González-Quintero VH, Istwan NB, Rhea DJ, Rodriguez LI, Cotter A, Carter J, Mueller A, Stanziano GJ. The impact of glycemic control on neonatal outcome in singleton pregnancies complicated by gestational diabetes. Diabetes Care 2007;30:467-470. (Pubitemid 46354319)
12. Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, Hod M, et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007;30 Suppl 2:S251-S260. (Pubitemid 47036434)
13. Canadian Diabetes Association. Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Canadian Journal of Diabetes, 2008; 32: S171-78.
14. Tieu J, Coat S, Hague W, Middleton P. Oral anti-diabetic agents for women with pre-existing diabetes mellitus/impaired glucose tolerance or previous gestational diabetes mellitus. Cochrane Database Syst Rev 2010;10:CD007724.
15. Sobngwi E, Boudou P, Mauvais-Jarvis F, Leblanc H, Velho G, Vexiau P, Porcher R, et al. Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet 2003;361:1861-1865. (Pubitemid 36645181)
16. Silverman BL, Metzger BE, Cho NH, Loeb CA. Impaired glucose tolerance in adolescent offspring of diabetic mothers. Relationship to fetal hyperinsulinism. Diabetes Care 1995;18:611-617.
17. Balaji V, Seshiah V. Management of diabetes in pregnancy. J Assoc Physicians India 2011;59 Suppl:33-36.
18. Wong VW, Jalaludin B. Gestational diabetes mellitus: who requires insulin therapy? Aust N Z J Obstet Gynaecol 2011;51:432-436.
19. Bernasko J. Intensive insulin therapy in pregnancy: strategies for successful implementation in pregestational diabetes mellitus. J Matern Fetal Neonatal Med 2007;20:125-132. (Pubitemid 47221627)
20. Whitelaw A. Subcutaneous fat in newborn infants of diabetic mothers: An indication of quality of diabetic control. Lancet 1977;1:15-18. (Pubitemid 8006493)
21. Mirghani H, Zayed R, Thomas L, Agarwal M. Gestational diabetes mellitus: fetal liver length measurements between 21and 24 weeks' gestation. J Clin Ultrasound 2007;35:34-37. (Pubitemid 46106454)
22. Bethune M, Bell R. Evaluation of the measurement of the fetal fat layer, interventricular septum and abdominal circumference percentile in the prediction of macrosomia in pregnancies affected by gestational diabetes. Ultrasound Obstet Gynecol 2003;22:586-590. (Pubitemid 38058000)
23. Larciprete G, Valensise H, Vasapollo B, Novelli GP, Parretti E, Altomare F, Di Pierro G, et al. Fetal subcutaneous tissue thickness (SCTT) in healthy and gestational diabetic pregnancies. Ultrasound Obstet Gynecol 2003;22:591-597. (Pubitemid 38058001)
24. Vink JY, Poggi SH, Ghidini A, Spong CY. Amniotic fluid index and birth weight: is there a relationship in diabetics with poor glycemic control? Am J Obstet Gynecol 2006;195:848-850. (Pubitemid 44292151)
25. de Veciana M, Major CA, Morgan MA, Asrat T, Toohey JS, Lien JM, Evans AT. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995;333:1237-1241.
26. Manderson JG, Patterson CC, Hadden DR, Traub AI, Ennis C, McCance DR. Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. Am J Obstet Gynecol 2003;189:507-512.
27. Leguizamón G, Krupitzki H, Glujovsky D, Olivera Ravasi M, Reece EA. Blood glucose monitoring in gestational diabetes mellitus: 1- versus 2-h blood glucose determinations. J Matern Fetal Neonatal Med 2002;12:384-388. (Pubitemid 36078498)
28. Moses RG, Lucas EM, Knights S. Gestational diabetes mellitus. At what time should the postprandial glucose level be monitored? Aust N Z J Obstet Gynaecol 1999;39:457-460.
29. Chen R, Yogev Y, Ben-Haroush A, Jovanovic L, Hod M, Phillip M. Continuous glucose monitoring for the evaluation and improved control of gestational diabetes mellitus. J Matern Fetal Neonatal Med 2003;14:256-260. (Pubitemid 37340295)
30. de Valk HW, Visser GH. Insulin during pregnancy, labour and delivery. Best Pract Res Clin Obstet Gynaecol 2011;25:65-76.
31. Montaner P, Ripollés J, Pamies C, Corcoy R. Measurement of fasting ketonuria and capillary blood glucose after main meals in women with gestational diabetes mellitus: How well is the metabolic picture captured? J Obstet Gynaecol Res 2011;37:722-728.
32. Jovanovic L. The role of continuous glucose monitoring in gestational diabetes mellitus. Diabetes Technol Ther 2000;2 Suppl 1:S67-S71. (Pubitemid 32107475)
33. Evers IM, de Valk HW, Mol BW, ter Braak EW, Visser GH. Macrosomia despite good glycaemic control in Type I diabetic pregnancy; results of a nationwide study in The Netherlands. Diabetologia 2002;45:1484-1489.
34. Kyne-Grzebalski D, Wood L, Marshall SM, Taylor R. Episodic hyperglycaemia in pregnant women with well-controlled Type 1 diabetes mellitus: a major potential factor underlying macrosomia. Diabet Med 1999;16:702-706.
35. Jovanovic L. What is so bad about a big baby? Diabetes Care 2001;24:1317-1318.
36. Zorn TM, Zúñiga M, Madrid E, Tostes R, Fortes Z, Giachini F, San Martín S. Maternal diabetes affects cell proliferation in developing rat placenta. Histol Histopathol 2011;26:1049-1056.
37. Maulik D, Lysikiewicz A, Sicuranza G. Umbilical arterial Doppler sonography for fetal surveillance in pregnancies complicated by pregestational diabetes mellitus. J Matern Fetal Neonatal Med 2002;12:417-422. (Pubitemid 36078504)
38. Elchalal U, Ezra Y, Levi Y, Bar-Oz B, Yanai N, Intrator O, Nadjari M. Sonographically thick placenta: a marker for increased perinatal risk-a prospective cross-sectional study. Placenta 2000;21:268-272. (Pubitemid 30240795)
39. Kofinas A, Kofinas G. Differences in amniotic fluid patterns and fetal biometric parameters in third trimester pregnancies with and without diabetes. J Matern Fetal Neonatal Med 2006;19:633-638. (Pubitemid 44804790)
40. Moore TR. Diabetes in pregnancy. In: Creasy RK, Resnik R, editors. Maternal fetal medicine, principles and practice. Philadelphia: WB Saunders; 1994. pp 934.
41. Suhonen L, Teramo K. Hypertension and pre-eclampsia in women with gestational glucose intolerance. Acta Obstet Gynecol Scand 1993;72:269-272. (Pubitemid 23265623)
42. Joffe GM, Esterlitz JR, Levine RJ, Clemens JD, Ewell MG, Sibai BM, Catalano PM. The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 1998;179:1032-1037. (Pubitemid 28489303)
43. Sibai BM, Ross MG. Hypertension in gestational diabetes mellitus: pathophysiology and long-term consequences. J Matern Fetal Neonatal Med 2010;23:229-233.
44. Tan YY, Yeo GS. Impaired glucose tolerance in pregnancy-is it of consequence? Aust N Z J Obstet Gynaecol 1996;36:248-255. (Pubitemid 26278518)
45. Oats JN, Beischer NA. Gestational diabetes. Aust N Z J Obstet Gynaecol 1986;26:2-10. (Pubitemid 16114144)
46. Yang X, Hsu-Hage B, Zhang H, Zhang C, Zhang Y, Zhang C. Women with impaired glucose tolerance during pregnancy have significantly poor pregnancy outcomes. Diabetes Care 2002;25:1619-1624. (Pubitemid 41071121)
47. Weiner CP. Effect of varying degrees of "normal" glucose metabolism on maternal and perinatal outcome. Am J Obstet Gynecol 1988;159:862-870. (Pubitemid 18266608)
48. Rey E, Monier D, Lemonnier MC. Carbohydrate intolerance in pregnancy: incidence and neonatal outcomes. Clin Invest Med 1996;19:406-415. (Pubitemid 27007932)
49. Roberts RN, Moohan JM, Foo RL, Harley JM, Traub AI, Hadden DR. Fetal outcome in mothers with impaired glucose tolerance in pregnancy. Diabet Med 1993;10:438-443. (Pubitemid 23163761)
50. Langer O. When diet fails: insulin and oral hypoglycemic agents as alternatives for the management of gestational diabetes mellitus. J Matern Fetal Neonatal Med 2002;11:218-225. (Pubitemid 34836910)
51. Cheng YW, McLaughlin GB, Esakoff TF, Block-Kurbisch I, Caughey AB. Glucose challenge test: screening threshold for gestational diabetes mellitus and associated outcomes. J Matern Fetal Neonatal Med 2007;20:903-908. (Pubitemid 350207563)